Furthermore, there are studies that suggest that elevated serum levels of CA19-9 are also associated with CCA recurrence [27, 41], a result corroborated by our study with soluble CD44, CD44v6, CD44v8-10, EpCAM and CA19-9. The gene discussed is EPCAM; the disease is cholangiocarcinoma.